Phase 1 trial of recombinant human interleukin-1β (rhIL-1β), carboplatin, and etoposide in patients with solid cancers: Southwest oncology group study 8940

John Rinehart, Evan Hersh, Brian Issell, Pierre Triozzi, William Buhles, James Neidhart

Research output: Contribution to journalArticle

30 Scopus citations

Fingerprint Dive into the research topics of 'Phase 1 trial of recombinant human interleukin-1β (rhIL-1β), carboplatin, and etoposide in patients with solid cancers: Southwest oncology group study 8940'. Together they form a unique fingerprint.

Medicine & Life Sciences